申请人:——
公开号:US06420403B1
公开(公告)日:2002-07-16
The present invention discloses the identification of the novel inhibitors of IMPDH (inosine-5′-monophosphate dehydrogenase). The compounds and pharmaceutical compositions disclosed herein are useful in treating or preventing IMPDH-associated disorders, such as transplant rejection and autoimmune diseases.
本发明揭示了IMPDH(次黄嘌呤-5'-单磷酸脱氢酶)的新型抑制剂的识别。本文所披露的化合物和药物组合物在治疗或预防与IMPDH相关的疾病方面具有用途,如移植排斥和自身免疫疾病。